CLINICAL_TRIALS
trial_result
· 2024-09-19
Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Mavacamten in Chinese Adults With Symptomatic Obstructive HCM [Phase 3]
Summary
Phase 3 trial in Chinese adults with symptomatic obstructive hypertrophic cardiomyopathy evaluating mavacamten; results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: LianBio LLC | Conditions: Obstructive Hypertrophic Cardiomyopathy | Phase 3 | Status: COMPLETED | Results posted: 2024-09-19